Solutions forSymptomaticVenous SinusStenosis

About VS3 Medical

VS3 Medical, Inc. is a privately held medical device company focused on delivering optimized solutions to address symptomatic venous sinus stenosis and overcome the unique challenges of the dural venous sinus anatomy. The VS3 Medical Stent System is an investigational device and is not available for sale.

Leadership Team

Thomas C. Wilder

Chief Executive Officer

Matthew Amans, MD

Founder

Mike Horzewski

Co-Founder, Chief Operating Officer

Mary Lou Mooney

VP, Regulatory, Clinical & Quality Affairs

Nick deBeer

Vice President, Research & Development

Gita Barry

Chief Marketing Officer

Investors

Investors - USVP, Santé Ventures, Gilde Healthcare, Aperture Venture Partners OSF HealthCare Ascension Ventures

Latest News & Updates

Press Release · September 29, 2026

VS3 Medical Receives FDA Breakthrough Device Designation for VS3 System to Treat Debilitating Pulsatile Tinnitus

The U.S. Food and Drug Administration has granted Breakthrough Device Designation to the VS3 System, based on evidence that it has the potential to resolve debilitating pulsatile tinnitus due to venous sinus stenosis.

Read More
Press Release · March 9, 2026

VS3 Medical Announces First Patients Enrolled in First-in-Human Study of Novel Neurovascular Implant to Address Symptomatic Venous Sinus Stenosis

The first cases enrolled were presented at the 2026 Society of Neuroinventional Surgery (SNIS) Cerebral Venous and CSF Disorders Summit, held March 5-7, 2026, in Colorado Springs, Colo.

Read More
In The News · March 9, 2026

The day the 'whooshing' stopped: World-first trial at The Ottawa Hospital brings relief from pulsatile tinnitus

For four and a half years, Kayleigh Baldock's life was consumed by a relentless, pounding "whooshing" sound in one ear accompanied by frequent migraine headaches.

Read More